Good Survival After Laparoscopic Radical Cystectomy
Recurrence-free survival was 66 percent at five years for patients with bladder cancer who had laparoscopic radical cystectomy.
Recurrence-free survival was 66 percent at five years for patients with bladder cancer who had laparoscopic radical cystectomy.
A 15-feature ‘genomic classifier’ surpassed the prognostic potential of standard clinical variables for bladder cancer risk.
Study shows a significantly better 5-year cancer-specific survival rate compared with radical cystectomy.
Their risk of death is 40% lower than that of patients who are not obese, study shows.
Venous thromboembolism is more likely to occur in patients with neurologic comorbidities and increased operative time.
It offers a survival benefit regardless of age, but is used less often in patients aged 70 years and older than in younger patients.
Radical cystectomy and chemo-radiation offer significantly better survival than other treatments or no treatment, study shows.
The 5-year recurrence-free and cancer-specific survival rates with robot-assisted radical cystectomy are 52.5% and 67.8%, respectively.
A study published recently in BJU International demonstrated that NAC does not increase the risk.
Compared with whites, Hispanics had an 88% increased odds of major post-cystectomy complications.